GFM
HRMY icon

GF Fund Management’s Harmony Biosciences HRMY Stock Holding History

GF Fund Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7K Sell
1,227
-67
-5% -$2.11K ﹤0.01% 400
2026
Q1 		$36.2K Buy
1,294
+163
+14% +$5.34K ﹤0.01% 436
2025
Q4 		$42.3K Sell
1,131
-107
-9% -$3.52K ﹤0.01% 420
2025
Q3 		$34.1K Sell
1,238
-222
-15% -$7.65K ﹤0.01% 434
2025
Q2 		$46.1K Hold
1,460
– – ﹤0.01% 424
2025
Q1 		$48.5K Buy
1,460
+262
+22% +$9.39K ﹤0.01% 423
2024
Q4 		$41.2K Buy
+1,198
New +$41.2K ﹤0.01% 408

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's HRMY Position: Q2 2026 in Review

GF Fund Management reduced its Harmony Biosciences (HRMY) stake by 5.2% in Q2 2026, selling an estimated $2.11K and leaving 1,227 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #400.

GF Fund Management first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $48.5K in Q1 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • GF Fund Management held 1,227 shares of Harmony Biosciences worth $44.7K as of Q2 2026.
  • GF Fund Management sold 67 Harmony Biosciences shares in Q2 2026, an estimated $2.11K.
  • Harmony Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #400 holding.
  • GF Fund Management first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Harmony Biosciences position peaked at $48.5K in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.